Xirodimas Dimitris P, Chisholm June, Desterro Joana M S, Lane David P, Hay Ronald T
University of Dundee, Ninewells Hospital and Medical School, Department of Surgery and Molecular Oncology, UK.
FEBS Lett. 2002 Sep 25;528(1-3):207-11. doi: 10.1016/s0014-5793(02)03310-0.
p14ARF tumour suppressor stabilises and activates p53 by directly interacting with (H)Mdm2 [(human) murine double minute 2 homologue] and inhibiting its E3 ubiquitin ligase activity. Here we demonstrate that p14ARF promotes accumulation of (H)Mdm2 conjugated to the small ubiquitin-like protein SUMO-1. Mutational analysis demonstrated that the N-terminus of Mdm2 is a target for p14ARF-mediated SUMO conjugation. SUMO modification requires residues 2-14 in p14ARF that interact with (H)Mdm2 and residues 82-101 in exon 2 involved in nucleolar localisation of p14ARF. These data suggest a novel role for p14ARF as a regulator of activity of (H)Mdm2, which could be related to its tumour suppressing activities.
p14ARF肿瘤抑制因子通过与(人/鼠)双微体2同源物(H)Mdm2直接相互作用并抑制其E3泛素连接酶活性,来稳定并激活p53。在此我们证明,p14ARF促进与小泛素样蛋白SUMO-1缀合的(H)Mdm2的积累。突变分析表明,Mdm2的N末端是p14ARF介导的SUMO缀合的靶点。SUMO修饰需要p14ARF中与(H)Mdm2相互作用的2至14位残基以及参与p14ARF核仁定位的外显子2中的82至101位残基。这些数据表明p14ARF作为(H)Mdm2活性调节剂具有新的作用,这可能与其肿瘤抑制活性有关。